Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial
Vivianne C. G. Tjan‐Heijnen(Maastricht University Medical Centre), R. Vree, P.H.A. Nijhuis, Johan Hygum Dam, Maurice J.C. van der Sangen(Radboud University Nijmegen), Ankie M.T. van der Velden, I.E. Arntz(The Netherlands Cancer Institute), Hein B.A.C. Stockmann(Spaarne Gasthuis), Aart Beeker(Spaarne Ziekenhuis), Judith R. Kroep(Leiden University Medical Center), Rudi M. H. Roumen(Radboud University Nijmegen), R.J.B. Blaisse(Rijnstate Hospital), Frans Erdkamp, Diederik F.S. Kehrer, J.M.G.H. van Riel, Mariëtte J Agterof(University Medical Center Utrecht), Grard A. P. Nieuwenhuijzen(Radboud University Nijmegen), Gerrit-Jan Veldhuis, Marien O. den Boer(Zuyderland Medisch Centrum), T van Dalen, Theo van Voorthuizen, Jacobus J. M. van der Hoeven(Radboud University Nijmegen), Allert H. Vos, Carolien H. Smorenburg(Amsterdam Public Health), R.A. Hellingman(Zuyderland Medisch Centrum), Adriaan J van Overbeeke, Aart van Bochove(Amsterdam Public Health), Sabine C. Linn(Oncode Institute), Alexander L.T. Imholz(Deventer Ziekenhuis), G. S. Madretsma, Ron Koelemij, L.J.A. Strobbe, F.A.A. Valster, Irene E.G. van Hellemond(Maastricht University), Onno R. Guicherit(Bronovo Hospital), E.A. Kouwenhoven(Ziekenhuis Groep Twente), J. K. S. Nuytinck, Maaike de Boer(Maastricht University), W Roos(Leiden University), Hiltje de Graaf(Medisch Centrum Leeuwarden), Franchette W.P.J. van den Berkmortel(Zuyderland Medisch Centrum), Caroline Seynaeve(Radboud University Nijmegen), Petronella G.M. Peer, Bea C. Tanis(Leiden University Medical Center), Jos Kitzen(Erasmus MC), Marnix A.J. de Roos(Ziekenhuis Gelderse Vallei), Aafke H. Honkoop(Isala), Ester Siemerink, Astrid C P Swinkels(Netherlands Comprehensive Cancer Organisation), W.J.B. Mastboom
Cited by 158
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|795